Related Experiment Video
Updated: Mar 29, 2026

09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
15.7K
Expression of CD30 as a biomarker to predict response to brentuximab vedotin
Mina L Xu1, Carlos Acevedo-Gadea2, Stuart Seropian2
1Department of Pathology, Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA.
Histopathology
|December 10, 2015
Abstract
No abstract available in PubMed .

